# Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

> **NCT01642706** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 240 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Osteoarthritis
- Systemic Lupus Erythematosus
- Sjogren's Syndrome
- Scleroderma
- Spondylitis
- Gout
- Spinal Disease
- Chondrocalcinosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01642706
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07-02
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642706, "Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01642706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*